Sign in to Administration. The default account is administrator with blank password.
Home News Latest News HPRA Drug Safety Newsletter Edition 86

HPRA Drug Safety Newsletter Edition 86

Home News Latest News HPRA Drug Safety Newsletter Edition 86
March 28, 2018

The 86th edition of the HPRA Drug Safety Newsletter.

The 86th edition of the HPRA Drug Safety Newsletter (DSN) includes important updates to support safe and appropriate use of the following medicines:

  • Esmya 5mg Tablets (Ulipristal acetate) - Important new warnings of serious liver injury and recommendations for liver monitoring

  • Xofigo (radium-223 dichloride) - Contraindicated in combination with Zytiga (abiraterone acetate) and prednisone/prednisolone

  • Mycophenolate - Updated contraceptive advice for male patients

  • Oral Retinoids - Outcome of EU review and updated warnings

  • Zinbryta (daclizumab beta) - EMA recommends immediate suspension and recall

  • Direct Healthcare Professional Communications published on the HPRA website since the last Drug Safety Newsletter 

Subscribe to our eZine

Receive our monthly newsletter with news and other content relevant to the Irish nursing and midwifery professions.